VPS54 (Vacuolar Protein Sorting 54, also known as Vam6p in yeast) is a key component of the vacuolar protein sorting machinery that plays critical roles in endolysosomal trafficking. Located on chromosome 2p21, VPS54 is particularly important in neurons due to their specialized endolysosomal requirements for synaptic function and protein quality control. Mutations in VPS54 are associated with amyotrophic lateral sclerosis (ALS) and hereditary spastic paraplegia (HSP)[1][2].
VPS54 is a core component of two critical trafficking complexes: the CORVET (Core Vacuolar Protein Sorting) complex and the HOPS (Homotypic Fusion and Vacuole Protein Sorting) complex. These complexes orchestrate membrane fusion events essential for endolysosomal function, which is critical for neuronal survival.
| Property | Value |
|---|---|
| Symbol | VPS54 |
| Full Name | Vacuolar Protein Sorting 54 |
| Previous Names | VPS54L, SVL |
| Chromosomal Location | 2p21 |
| NCBI Gene ID | 51542 |
| OMIM | 610412 |
| Ensembl ID | ENSG00000143952 |
| UniProt ID | Q9P1C0 |
| Gene Length | ~37 kb |
| Exons | 20 coding exons |
The VPS54 protein is 972 amino acids in length with a molecular weight of approximately 110 kDa. It contains multiple protein-protein interaction domains including an N-terminal proline-rich region and C-terminal coiled-coil domains.
VPS54 contains several functional domains:
VPS54 is a central regulator of membrane trafficking within the endolysosomal system:
VPS54 functions as part of the Class C Core Vacuolar Protein Sorting (CORVET) complex, which regulates early endosome tethering and fusion. The CORVET complex includes:
This complex is essential for early endosome fusion and cargo sorting[3].
VPS54 also functions in the Homotypic Fusion and Vacuole Protein Sorting (HOPS) complex, which mediates late endosomal and lysosomal fusion. The HOPS complex contains:
The HOPS complex is particularly important for lysosomal function and autophagosome-lysosome fusion[yang2021].
In neurons, VPS54 plays several critical roles:
VPS54 is highly expressed in:
VPS54 mutations have been identified in ALS patients, particularly in early-onset cases:
Pathogenic Mechanisms:
Cellular Phenotypes:
Therapeutic Implications[4][5]:
VPS54 mutations cause a distinctive form of hereditary spastic paraplegia characterized by:
Clinical Features:
Pathogenesis:
Reduced VPS54 expression has been reported in AD brains:
VPS54 may be involved in alpha-synuclein clearance:
VPS54 deficiency leads to multiple cellular abnormalities:
Endosome Maturation Defects:
Lysosomal Impairment:
Autophagy Disruption[6]:
VPS54 is critical for synaptic function:
Vesicle Recycling:
Postsynaptic Function:
Lysosomal Enhancers:
Autophagy Modulators:
Trafficking Modulators:
VPS54 Overexpression:
CRISPR Approaches:
Combining endolysosomal enhancement with other strategies:
| Partner | Complex | Function |
|---|---|---|
| VPS11 | CORVET/HOPS | Core component |
| VPS16 | CORVET/HOPS | Scaffold |
| VPS18 | CORVET/HOPS | Core component |
| VPS33A/B | CORVET/HOPS | SNARE regulation |
| VPS39 | HOPS | Tethering |
| VPS41 | HOPS | Membrane docking |
VPS54 intersects with:
VPS54-related biomarkers:
Key research priorities:
VPS54 represents an important therapeutic target due to its central role in endolysosomal trafficking and neuronal function[5:1].
Strathdee CA, et al. VPS54, the end-of-mitosis checkpoint complex and cancer. Oncogene. 2002. ↩︎
Eriksson P, et al. The neuronal trafficking protein VPS54 is reduced in the brains of Alzheimer's disease patients. Exp Neurol. 2005. ↩︎
Zavodszky E, et al. Mutations in VPS54 impair endolysosomal trafficking and contribute to neurodegeneration. Nat Commun. 2018. ↩︎
Liu Y, et al. VPS54 mutations in early-onset ALS: clinical and cellular characterization. Neurology. 2023. ↩︎
Miller S, et al. Endolysosomal trafficking proteins as therapeutic targets in neurodegeneration. Nat Rev Neurol. 2024. ↩︎ ↩︎
Kim HJ, et al. VPS54 deficiency leads to impaired autophagy and protein aggregate accumulation. Autophagy. 2021. ↩︎
Ago Y, et al. VPS54 regulates neural stem cell differentiation via Wnt/beta-catenin signaling. Stem Cells. 2015. ↩︎